In all instances, deep deletions and gene amplifications are extremely rare, generally occurring in <1% of all cancers, except for CUL1 amplifications that occur in ~7% of ovarian cancer cases (Figure 3C). This evidence concerns the gene CUL1 and ovarian carcinoma.